HOYA's children deserve better – HOYA Vision Care calls for urgent action to address childhood myopia

May 31, 2024 07:23 PM AEST | By EIN Presswire
 HOYA's children deserve better – HOYA Vision Care calls for urgent action to address childhood myopia
Image source: EIN Presswire
Now is the time for our healthcare ecosystems to work together and act collectively upon awareness and education”
— Alexandre Montague, CEO HOYA Vision Care
LONDON, UNITED KINGDOM , May 31, 2024 /EINPresswire.com/ -- Ophthalmic lens technology leader HOYA Vision Care reinforces its commitment in slowing down myopia progression in children through its innovative advances in MiYOSMART spectacle lenses.

Myopia, also known as short-sightedness, is a common eye condition whereby objects far away appear out of focus. By 2050, an estimated 5 billion people could be affected by myopia and annual myopia progression rate is most rapid under 10 years of age. Childhood myopia is a growing global problem due to factors such as increased near-work activities including the usage of digital devices and spending less time outdoors, but there is a lack of awareness of this condition and impact amongst patients and the parents of children living with myopia.

The risk of complications increased exponentially with increasing degrees of myopia.
Dr. Serge Resnikoff, Chair of the International Myopia Institute said, “There are fundamental differences between having low and high myopia. People with high myopia have a higher risk in developing complications such as macular degeneration, retinal detachment or even glaucoma which may lead to irreversible blindness.” However, there is still no safe level of myopia. Despite the risk of complications being modest at low levels of myopia, it is still a public health threat. In fact, 41.6% of cases of MMD were found in low myopes.

HOYA Vision Care calls for urgent action to mitigate the burden of myopia by making it a global priority for governments and public health bodies to act collectively to ensure early detection, increase education and awareness. The urgency to prioritize myopia stems from the multi-faceted impact on patients, communities, and healthcare systems. As the prevalence of myopia is increasing, it is also imperative for governments and public health bodies to prioritize its treatment as a public health concern to improve the quality of life for children living with this condition as well as educate on preventive solutions.

Treating myopia in children early helps not only correct their vision but also provide myopia management solutions earlier to slow down the myopia progression and preserve their vision and eye health for the future. MiYOSMART is a spectacle lens based on revolutionary Defocus Incorporated Multiple Segments (D.I.M.S.) Technology. In a 2-year randomised controlled clinical study, wearing of MiYOSMART spectacle lenses slowed down myopia progression on average by 60%, compared to wearing standard single vision spectacle lenses. 1 in 5 children also had no myopia progression at all within 2 years of wear. The 6-year follow-up clinical study also revealed that the myopia management effect was sustained over 6 years, demonstrating that there is benefit in wearing the spectacle lenses long term.

“Now is the time for our healthcare ecosystems to work together and act collectively upon awareness and education. Our children deserve better – the impact of myopia on our children’s lives should not be overlooked with it affecting their education and quality of life,” said Alexandre Montague, CEO HOYA Vision Care. The success of MiYOSMART is only the first step. We’re calling for increased efforts to raise awareness, educate Eye Care Professionals, educate parents through Eye Care Professionals about the condition and the importance of diagnosing, monitoring and seeking timely treatment for their children.”

Every child deserves to have better treatment for their vision health. MiYOSMART is available in more than 30 countries* worldwide and over 2 million parents across the world have already trusted the solution for their children.

*MiYOSMART has not been approved for myopia management in all countries, including the United States, and is not currently available for sale in all countries, including the United States.

Watch the Global Health Campaign here

About HOYA Vision Care
As a global leader in optical technology, HOYA Vision Care is dedicated to providing innovative vision care solutions for every stage of a patient’s life. A steadfast partner to Eye Care Professionals around the world, it stands at the forefront of optical excellence. With a global presence, consisting of 43 laboratories and a growing team of 20,000 employees, HOYA Vision Care delivers innovative lenses and other vision care solutions to millions of people in 110 countries.

Lemia El Basri
Acumen Media
+44 20 3553 3664
email us here


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.